You have reached your limit of free articles this month.

Enjoy unlimited access to myStatesman.com

Starting at just 99¢ for 8 weeks.

GREAT REASONS TO SUBSCRIBE TODAY!

  • IN-DEPTH REPORTING
  • INTERACTIVE STORYTELLING
  • NEW TOPICS & COVERAGE
  • ePAPER
X

You have read of premium articles.

Get unlimited access to all of our breaking news, in-depth coverage and bonus content- exclusively for subscribers. Starting at just 99¢ for 8 weeks

X

Welcome to myStatesman.com

This subscriber-only site gives you exclusive access to breaking news, in-depth coverage, exclusive interactives and bonus content.

You can read free articles of your choice a month that are only available on myStatesman.com.

Cancer pill could keep patients alive for more than 10 years, new study finds


Before cancer drug imatinib mesylate, sold under the name Gleevec, a diagnosis for chronic myeloid leukemia (CML) "amounted to a death sentence," according to the U.S. National Cancer Institute.

Now, the drug could keep its patients alive for 10 years or longer, a new study published in the New England Journal of Medicine Thursday found.

>> Read more trending stories

Data from the global study, which enrolled 1,106 participants at 177 cancer centers in more than 16 countries, showed that the once-a-day pill helped 83 percent of its patients extend their lives for at least a decade.

Prior to the Food and Drug Administration’s approval of the drug in 2001, less than one in three CML patients survived five years past their diagnosis, according to a news release ono the study from Oregon Health & Science University.

» RELATED: 6 incredibly rare diseases you’ve probably never heard of 

"This has been the thrill of my life," Dr. Richard Silver, a hematologist and oncologist in New York who helped test the drug in patients, told NBC News.

According to Silver, Gleevec is the first targeted personalized medicine ever used -- and the most successful.

» RELATED: 3 young cancer survivors share happy update 

One of the surviving patients is Bharat Shah, who told NBC News he had six months to three years to live upon his diagnosis in 2000.

After joining a clinical trial of Gleevec, Shah said he was back to normal within two months. After 17 years using the drug, the only side effect is that his eyes get a little puffy.

Gleevec also proved effective against other forms of cancer, including pediatric CML and gastrointestinal stromal tumor (GIST), the study found.

Common side effects, according to the study, included nausea, fatigue, itchy skin and muscle pain.


Reader Comments ...


Next Up in Local

UPDATE: Missing officer emails woman, says plan to fake death and flee to Mexico was successful, officials say
UPDATE: Missing officer emails woman, says plan to fake death and flee to Mexico was successful, officials say

An Austin police officer who was originally reported missing is believed to have attempted to fake his own death and to have fled to Mexico, officials said Friday night. Officer Coleman Martin, 29, is facing a Class A misdemeanor charge of “false report,” as a result. Anyone who knows where Martin is should call the Austin Police Department...
At trial, Alex Jones blurred the line between Infowarrior and parent
At trial, Alex Jones blurred the line between Infowarrior and parent

At an April 12 pretrial hearing, state District Judge Orlinda Naranjo said she wouldn’t allow the jury at an upcoming child custody trial to watch a recent Infowars video in which Alex Jones, in an obscene, gay-bashing rant threatened U.S. Rep. Adam Schiff, the top Democrat on the House Intelligence Committee, because the judge didn’t want...
Amid controversy, Austin school police chief takes another job
Amid controversy, Austin school police chief takes another job

Austin school district Police Chief Eric Mendez is expected to announce his resignation Monday morning, taking another police chief position in another organization. The announcement comes just days after questions surfaced about whether his staff did enough to investigate a sexual assault allegation of a 4-year-old girl at Boone Elementary in February...
At trial, Alex Jones blurred the line between Infowarrior and parent
At trial, Alex Jones blurred the line between Infowarrior and parent

At an April 12 pretrial hearing, state District Judge Orlinda Naranjo said she wouldn’t allow the jury at an upcoming child custody trial to watch a recent Infowars video in which Alex Jones, in an obscene, gay-bashing rant threatened U.S. Rep. Adam Schiff, the top Democrat on the House Intelligence Committee, because the judge didn’t want...
NEW: AISD police chief leaving; DA says assault may not have occurred
NEW: AISD police chief leaving; DA says assault may not have occurred

Austin school district Police Chief Eric Mendez is expected to announce his resignation for another job Monday morning, days after questions surfaced about whether his staff did enough to investigate a sexual assault allegation of a 4-year-old at Boone Elementary in February, sources with knowledge of the investigation confirmed Friday night. The announcement...
More Stories